Co-Diagnostics, Inc. (CODX) vs VolitionRX Limited (VNRX)

Co-Diagnostics, Inc. and VolitionRX Limited are both Medical Devices companies. Co-Diagnostics, Inc. is the larger, with a market value of $8.3M against $6.9M — 1.2× the size. VolitionRX Limited grew revenue faster over the last twelve months: 86.3% against −28.1%. VolitionRX Limited has the higher net margin (−1,043.1% vs −6,522.9%) and the higher return on invested capital (0.00% vs −337.7%). Across the 17 metrics below, VolitionRX Limited leads on 13 and Co-Diagnostics, Inc. on 4.

Valuation

Metric CODX VNRX Medical Devices median
P/E n/m n/m 22.18
P/S 6.51 0.97 2.70
P/B 0.37 n/m 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 1.45 4.31 2.38
Earnings yield (2,464.05%) (1,469.23%) (8.22%)
Free cash flow yield (584.74%) (835.24%) (7.80%)

Profitability

Metric CODX VNRX Medical Devices median
Gross margin 43.47% 100.00% 56.01%
Operating margin (6,787.47%) (790.20%) (15.03%)
Net margin (6,522.91%) (1,043.08%) (20.40%)
Free cash flow margin (3,807.94%) (796.73%) (7.24%)
Return on equity (174.77%) 76.95% (15.32%)
Return on assets (149.25%) (301.54%) (19.72%)
Return on invested capital (337.68%) 0.00% (10.33%)

Growth

Metric CODX VNRX Medical Devices median
Revenue growth (TTM) (28.12%) 86.32% 8.80%
EPS growth (last fiscal year) 5.34% 29.03% —
Revenue growth, 5-year CAGR (61.60%) 164.28% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CODX VNRX Medical Devices median
Debt to equity 0.00 (0.33) 0.07
Current ratio 1.81 0.30 2.50
Net debt to EBITDA 0.24 (0.52) 0.49

Dividend

Metric CODX VNRX Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric CODX VNRX Medical Devices median
Market cap 8.28m 6.92m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack